Skip to content
Dose Brief
Menu
The shortlist

Alternatives to Try Ageless

Try Ageless sits at No. 357 in our ranking with a Brief Score of 58. Here are the GLP-1 providers we'd weigh against it — ranked on the same six-factor Brief Score, top down.

Prefer a straight head-to-head? CoreAge Rx vs Try Ageless.

Our top alternative

No. 1 here

CoreAge Rx

One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

Sema
$99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published
Tirz
$149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published
Coverage
US only; restrictions by state, confirmed at intake

More providers worth weighing

No. 135 · Grade C

VirtualCare2Go

72/100

VirtualCare2Go is a US telehealth provider offering compounded GLP-1 weight-loss medication with same-day visits and national shipping.

Sema
From $279/mo (starting dose, compounded)
Coverage
All 50 states
new to the tracker, no prior reading
No. 28 · Grade B

TeleCareSpot

85/100

A nationwide provider with an oral option — full-formulary, but priced at the premium end.

Sema
$299/mo
Coverage
All 50 states
price stable
No. 48 · Grade B−

Apex MD

80/100

Apex MD is a US virtual telemedicine platform licensed in all 50 states that prescribes compounded GLP-1 medications for weight loss.

Sema
$299/mo
Coverage
All 50 states
new to the tracker, no prior reading
No. 64 · Grade C

Clume Health

78/100

Clume Health charges $259 a month for compounded semaglutide or tirzepatide, the same figure for either, while the two prices on its homepage match nothing it actually sells.

Sema
From $259/mo (compounded)
Coverage
All 50 states and DC claimed, no list published
new to the tracker, no prior reading
No. 31 · Grade B−

Direct Meds

82/100

A newer (2024) compounding provider whose real hook is form: it runs an oral/sublingual line alongside the usual injections, on both molecules, with no membership tacked on.

Sema
$249/mo sublingual · $297/mo injectable — both billed monthly on a 3-month minimum commitment
Coverage
Not publicly listed
price stable

FDA warning letter, September 2025 — issued to directmeds.com, Inc. dba DirectMeds. See the FDA's warning letter database.

No. 204 · Grade C

RedBox Rx

68/100

RedBox Rx is a US telehealth pharmacy (parent company Hy-Vee) offering compounded GLP-1 weight management with flat, dose-independent pricing.

Sema
From $269/mo (all doses, 6-month plan, compounded)
Coverage
Coverage not published
new to the tracker, no prior reading
No. 80 · Grade C

MyDrHank

74/100

A six-shelf prescription telehealth catalog whose GLP-1 price genuinely holds flat as you titrate — but whose every advertised figure is a twelve-month prepay rate, with the month-to-month price published nowhere.

Sema
$259/mo (month-to-month; prepay tiers lower)
Coverage
44 states (not KS, LA, MS, NM, ND, WV)
new to the tracker, no prior reading
No. 225 · Grade C

Tell Her Doc

67/100

Tell Her Doc is a women-focused, self-pay telehealth program for compounded GLP-1 weight loss — compounded semaglutide and tirzepatide in injection, oral, and orally-dissolving-tablet forms, plus microdoses.

Sema
From $269/mo (microdose tier, plus a separate fee, compounded)
Coverage
All 50 states
new to the tracker, no prior reading

On the record

The FDA issued a warning letter to Lovely Meds, Inc. dba Lovely Meds in September 2025. Try Ageless's own medical-oversight page identifies Lovely Meds, Inc. as the company that operates tryageless.com. The letter concerns lovelymeds.com, does not name tryageless.com, and FDA has not closed it out. Try Ageless keeps its place here and its link is unchanged — but you should know the letter exists before you start care. Read it in the FDA's warning letter database.

Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.